Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-171-5 | CAS number: 28706-25-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
No adverse effects were observed in a subacute oral (gavage) toxicity study in rats with the read across substance Analogue substance 1 at 1000 mg/kg/day (highest dose tested). The study predated GLP and OECD guidelines.
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Additional information
Repeated dose toxicity:
The endpoint for repeated dose toxicity is based on a read across from an oral toxicity study performed with Analogue substance 1 (CIBA 1979). In a pre-GLP study male and female rats (Tif:RAlf, SPF; 20/sex/group) received the substance by oral gavage on 5 days a week over a period of 30 days (in total 22 doses). The treatment period was followed by a 2 -week recovery period. No effects were observed on food consumption, body weight, clinical signs, clinical laboratory examinations and pathology. Eye examination did not reveal any ocular changes. No loss of hearing ability was registered. It can be concluded from the observations made during this study that 1000 mg/kg/day of Analogue substance 1 produced no observable effects in male and female rats.
In support of this study a second read across study with Analogue substance 1 is available. This study (Leist, 1982), non-GLP, was performed according to ETAD Toxicological method No. 006. Determination of subacute oral toxicity to rats (28-days test). The results of subacute toxicity studies on eight selected colorants of low acute oral toxicity (LD50 > 2000 mg/kg) are reported. These eight colorants, selected from widely differing chemical structural types, were administered as 22 daily doses over a period of 30 days (no weekend dosing) at 1000 mg/kg body weight/day by gavage to female and male rats. Animals treated with the vehicle served only as controls. In most cases the treatment period was followed by a 15day recovery period. At the end of the treatment and the recovery period, hematology, blood chemistry and urinalysis measurements were carried out by standard methods on animals from control and test groups; each rat was also examined externally and by dissection for macroscopic abnormalities. At the end each rat was autopsied and selected organs, including liver, kidneys, adrenals and spleen were submitted for histopathological examination, following determination of the organ weights. Even at this high dose level all products were tolerated without irreversilble signs of toxicity. The survey of data available indicated that the substances investigated exhibited a very low cumulative toxicity.
Further support is given in the study of Dystar (non-GLP and not conducted according to any specific guideline). The toxicity of the dye Analogue substance 1 was examined in 3- and 6-month feeding studies with weanling albino rats. Groups of 10 males and 10 females each were fed the dye at dietary levels of 0, 375, 750, 1500 or 3000 ppm for 13 weeks and of 0, 750, 1500 or 3000 ppm for about 28 weeks. General condition, behaviour, survival, growth, food intake and food efficiency were not adversely affected in any of the groups. Haematological and blood biochemichal parameters did not indicate a treatment-related effect of the dye. The percentage of eosinophils was slightly increased at 3000 ppm in females only. There were no changes in the composition of the urine which could be attributed to the treatment with Analogue substance 1. Organ weights did not show distinct differences between the test groups and the controls. Gross pathology failed to reveal changes that could be attributed to the test substance. Microscopically, there were minimal liver changes, viz. pronounced lobular pattern of the liver in the 1500 and 3000 ppm groups in males of the 6- month study only. It was concluded that the no toxic effect level of analogue substance 1 when fed to rats for 6 months was 750 ppm in the diet, or 37.5 mg/kg body weight/day, with the understanding that the effects found at the 1500 and 3000 ppm levels were only weak, aspecific and of doubtful, if any biological significance.
Justification for classification or non-classification
Based on the findings of the repeated dose toxicity study with the read across substance Analogue substance 1, the test substance does not need to be classified according to the Directive 67/548/EEC and the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
